Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP486269.RALzue-mhO4x8KdeaFbXM-voZCNUxbpjm3Srd7Fz_lt7E130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP486269.RALzue-mhO4x8KdeaFbXM-voZCNUxbpjm3Srd7Fz_lt7E130_assertion type Assertion NP486269.RALzue-mhO4x8KdeaFbXM-voZCNUxbpjm3Srd7Fz_lt7E130_head.
- NP486269.RALzue-mhO4x8KdeaFbXM-voZCNUxbpjm3Srd7Fz_lt7E130_assertion description "[We have previously observed that TGF-beta type II receptor (TbetaR-II) expression decreases in squamous cell carcinomas as tumors become less differentiated and more biologically aggressive.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP486269.RALzue-mhO4x8KdeaFbXM-voZCNUxbpjm3Srd7Fz_lt7E130_provenance.
- NP486269.RALzue-mhO4x8KdeaFbXM-voZCNUxbpjm3Srd7Fz_lt7E130_assertion evidence source_evidence_literature NP486269.RALzue-mhO4x8KdeaFbXM-voZCNUxbpjm3Srd7Fz_lt7E130_provenance.
- NP486269.RALzue-mhO4x8KdeaFbXM-voZCNUxbpjm3Srd7Fz_lt7E130_assertion SIO_000772 11410498 NP486269.RALzue-mhO4x8KdeaFbXM-voZCNUxbpjm3Srd7Fz_lt7E130_provenance.
- NP486269.RALzue-mhO4x8KdeaFbXM-voZCNUxbpjm3Srd7Fz_lt7E130_assertion wasDerivedFrom befree-20140225 NP486269.RALzue-mhO4x8KdeaFbXM-voZCNUxbpjm3Srd7Fz_lt7E130_provenance.
- NP486269.RALzue-mhO4x8KdeaFbXM-voZCNUxbpjm3Srd7Fz_lt7E130_assertion wasGeneratedBy ECO_0000203 NP486269.RALzue-mhO4x8KdeaFbXM-voZCNUxbpjm3Srd7Fz_lt7E130_provenance.